Biogen’s (BIIB) MS Drug, Vumerity, Gets Positive CHMP Opinion Posted byZacks Equity Research September 20, 2021 Leave a comment on Biogen’s (BIIB) MS Drug, Vumerity, Gets Positive CHMP Opinion The CHMP gives a positive opinion on, and recommends granting marketing authorization to Biogen’s (BIIB) Vumerity for the treatment of adults with rel…